Psoriasis

ARCA biopharma and Oruka Therapeutics have entered into a definitive merger agreement and will now operate under Oruka Therapeutics, ARCA announced in a press release.

In this Healio exclusive video, Steven R. Feldman, MD, PhD, discussed study results presented at the American Academy of Dermatology Annual Meeting examining bimekizumab in the treatment of psoriasis.

In this Healio exclusive video, Steven R. Feldman, MD, PhD, discussed psoriasis findings from the FRONTIER-2 study presented at the American Academy of Dermatology Annual Meeting.

In this Healio exclusive video, Steven R. Feldman, MD, PhD, discussed psoriasis research from the phase 2 STRIDE study presented at the American Academy of Dermatology Annual Meeting.

In this Healio exclusive video, Steven R. Feldman, MD, PhD, discussed psoriasis research from the phase 2 KNOCKOUT study presented at the American Academy of Dermatology Annual Meeting.

In this Healio exclusive video, Steven R. Feldman, MD, PhD, discussed psoriasis research from the American Academy of Dermatology Annual Meeting examining the LITE study in plaque-type psoriasis.

In this Healio exclusive video, Steven R. Feldman, MD, PhD, discussed hidradenitis suppurativa research from the American Academy of Dermatology Annual Meeting, examining two studies into its treatment.

Treating psoriasis with oral roflumilast may induce weight loss, positioning the drug as a potentially attractive alternative for patients with psoriasis, according to a study.

The FDA has approved an expanded indication for Spevigo injection to treat generalized pustular psoriasis in pediatric patients aged 12 years and older weighing 40 kg or more, Boehringer Ingelheim announced in a press release.

SAN DIEGO — Modulation of psoriasis biomarkers and pathways were observed in patients who experienced clinical success with TAK-279, according to phase 2b trial results.